Artivion (AORT) Cash from Financing Activities (2010 - 2026)
Artivion (AORT) reported Cash from Financing Activities of $463000.0 for Q1 2026, down 88.24% on a YoY basis from $3.9 million in Q1 2025, and down 80.95% quarter-over-quarter from $2.4 million in Q4 2025.
Artivion (AORT) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Artivion has reported Cash from Financing Activities for 17 years, with the latest figure at $463000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 88.24% year-over-year to $463000.0; the trailing twelve-month figure through Mar 2026 stood at $7.8 million (up 44.51% YoY), and the FY2025 full-year result was $11.3 million, up 412.12% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $463000.0, down from $2.4 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $3.9 million in Q1 2025, with the low at -$1.6 million in Q4 2023.
- Historically, Cash from Financing Activities has averaged $774941.2 across 5 years, with a median of $463000.0 in 2026.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities sank 460.71% — and 2025, when it surged 1535.36%.
- Artivion's Cash from Financing Activities stood at -$859000.0 in 2022, then tumbled by 89.76% to -$1.6 million in 2023, then soared by 110.67% to $174000.0 in 2024, then soared by 1296.55% to $2.4 million in 2025, then sank by 80.95% to $463000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $463000.0 (Q1 2026), $2.4 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Artivion | 1.02 Bn | 961.48 Mn | 75.45 Mn | 463,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 463,000.00 |
| Mar 31, 2026 | 463,000.00 |
| Dec 31, 2025 | 2.43 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Sep 30, 2025 | 2.32 Mn |
| Sep 30, 2025 | 2.32 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 3.94 Mn |
| Mar 31, 2025 | 3.94 Mn |
| Dec 31, 2024 | 174,000.00 |
| Dec 31, 2024 | 174,000.00 |
| Sep 30, 2024 | 1.47 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | -181,000.00 |
| Jun 30, 2024 | -181,000.00 |
| Mar 31, 2024 | 737,000.00 |
| Mar 31, 2024 | 737,000.00 |
| Dec 31, 2023 | -1.63 Mn |
| Dec 31, 2023 | -1.63 Mn |